Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,708.60
Bid: 1,708.40
Ask: 1,708.80
Change: 0.00 (0.00%)
Spread: 0.40 (0.023%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,708.60
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

23 Oct 2015 12:34

GlaxoSmithKline's Volibris drug receives positive recommendation

(ShareCast News) - A committee of the European Medicines Agency (EMA) has recommended GlaxoSmithKline's Volibris drug be approved for use in combination treatment for patients with pulmonary arterial hypertension. The Committee for Medicinal Products for Human Use (CHMP) announced the formal recomme

Read more
23 Oct 2015 12:22

WHO experts urge demo tests before wider use of malaria vaccine

GENEVA/LONDON, Oct 23 (Reuters) - The world's first malaria vaccine is promising but should be used on a pilot basis before any wide-scale use, given its limited efficacy, World Health Organization experts said on Friday. The Mosquirix shot, made by GlaxoSmithKline, could potentially help s

Read more
23 Oct 2015 10:12

Glaxo Gets Positive Opinion On Combination Use Of Volibris Drug

Read more
22 Oct 2015 20:56

GSK to profile new class of antibiotic at Nov. 3 investor day

LONDON, Oct 22 (Reuters) - British pharmaceutical company GlaxoSmithKline will profile its drug development pipeline, including a new class of antibiotic, on Nov. 3, its chief executive said on Thursday. The event in New York - the company's first investor day centred on drug development fo

Read more
22 Oct 2015 08:40

BROKER RATINGS SUMMARY: Merrill Lynch, JPMorgan Cut Pearson To Neutral

Read more
21 Oct 2015 15:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
21 Oct 2015 14:51

GSK joins China trade push as UK trumpets healthcare deals

LONDON, Oct 21 (Reuters) - GlaxoSmithKline's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly $500 million for bribing Chinese doctors. The group has since been rebuilding its position

Read more
21 Oct 2015 08:38

BROKER RATINGS SUMMARY: Citi Raises Smiths Group To Buy From Neutral

Read more
20 Oct 2015 13:22

GlaxoSmithKline announces positive results from Incruse Ellipsa studies

(ShareCast News) - GlaxoSmithKline announced positive results from two studies directly comparing the efficacy and safety of its Incruse Ellipta treatment for chronic obstructive pulmonary disease to two existing treatments. The pharmaceuticals giant said that results from a randomised, blinded stud

Read more
20 Oct 2015 12:11

GlaxoSmithKline Gets Positive Test Results For Incruse Ellipta

Read more
13 Oct 2015 16:41

Broker tips: Jupiter Fund Management, Ladbrokes, GSK

(ShareCast News) - RBC Capital Markets has upgraded Jupiter Fund Management as it believes current forecasts underestimate the group's inflows and capital returns. After Monday's trading update, RBC's new 'outperform' rating, up from the previous 'sector perform', is accompanied by a 3% increase in

Read more
13 Oct 2015 16:12

London close: Stocks close lower on UK deflation, weak Chinese trade data

(ShareCast News) - The FTSE 100 ended down 28.90 points to 6,342.28 on Tuesday as September data showed the UK experienced deflation and China's exports and imports declined. The Office for National Statistics said the UK consumer price index fell 0.1% year-on-year last month, compared to analysts'

Read more
13 Oct 2015 13:59

FTSE 100 movers: SAB surges on AB InBev agreement; Royal Mail slumps

(ShareCast News) - London's FTSE 100 was down 1.1% by mid afternoon at 6,304.21 as uninspiring Chinese trade figures and UK inflation data weighed on investors' minds. London-listed brewer SABMiller surged after it agreed in principle to a possible £44 per share takeover offer from Belgium-based Anh

Read more
13 Oct 2015 12:24

JPMorgan ups Glaxo to 'neutral', says consensus now looks achievable

(ShareCast News) - JPMorgan Cazenove upgraded GlaxoSmithKline to 'neutral' from 'underweight' and lifted the price target to 1,370p from 1,320p. The bank noted that medium-term consensus earnings per share estimates have fallen 15-18% year-to-date and expectations now look achievable, with downgrade

Read more
13 Oct 2015 09:49

Tuesday broker round-up

(ShareCast News) - Ladbrokes: Citigroup upgrades to neutral, raises target price to 110.00p. Jupiter Fund Management: RBC Capital Markets upgrades to outperform, bumps up target price to 475.00p. Jefferies reiterates to buy, lifts target price to 493.00p. Glaxosmithkline: JP Morgan Cazenove upgrade

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.